expert group recommends neonatal screening deficiency alpha1atd homozygous alpha1atd pizz occurs NUMBER NUMBER caucasian population NUMBER NUMBER individuals european population large regional variation risk factor predisposes mainly liver disease early infancy emphysema early adulthood importantly smoking decreases duration asymptomatic phase life expectancy y swedish alpha1at screening programme subsequent information advice prevented majority adolescents starting smoke involved parents alpha1atd adolescents retrospectively recommended neonatal screening potential advantages neonatal alpha1at screening early diagnosis treatment neonatal liver disease optimal treatment fever bacterial infections theoretically preventing liver cell damage genetic advice information consequences passive active smoking potential advantages postponing screening age identification alpha1atd close age smoking start possibility child screening decision disadvantages alpha1at screening psychosocial mother probably vulnerable neonatal discrimination insurance companies employers important uncertainties lack knowledge concerning participation voluntary alpha1at screening psychosocial reactions efficacy advice information given children families question screen alpha1atd topic lively debate alpha1 antitrypsin NUMBER NUMBER NUMBER 12y reactions period anti smoking school age